MoneyWorks4Me

Revenue showed a marginal decline at Rs. 9.29 millions. For the quarter ended September 2022, as compared to corresponding quarter of last year.The Total Profit for the quarter ended September 2022 of Rs. 5.22 millions grew from Rs.-1.88 millionsOP of the company witnessed a marginal growth to 6.79 millions from 0.09 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9.29 0.00 0.00 21.21 0.00 0.00 1.27 0.00 0.00
Other Income 19.91 11.19 77.93 44.00 315.83 -86.07 395.35 296.13 33.51
PBIDT 6.79 0.09 7444.44 16.57 288.12 -94.25 339.68 -85.32 -498.12
Interest 0.08 0.34 -76.47 0.41 0.93 -55.91 2.47 5.58 -55.73
PBDT 6.71 -1.38 -586.23 15.73 136.06 -88.44 36.44 -90.90 -140.09
Depreciation 0.43 0.47 -8.51 0.85 0.95 -10.53 1.92 3.78 -49.21
PBT 6.28 -1.85 -439.46 14.88 135.11 -88.99 34.52 -94.68 -136.46
TAX 1.06 0.03 3433.33 1.11 -0.39 -384.62 4.96 -0.81 -712.35
Deferred Tax 1.06 0.03 3433.33 1.11 -0.39 -384.62 7.46 -2.91 -356.36
PAT 5.22 -1.88 -377.66 13.77 135.50 -89.84 29.56 -93.87 -131.49
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 73.09 0.00 0.00 78.12 0.00 0.00 26746.46 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..